基于芯片重注释筛选并构建影响三阴性乳腺癌复发转移风险的5-lncRNA预后模型

来源 :2019中国肿瘤学大会 | 被引量 : 0次 | 上传用户:guosuzhou
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  目的 乳腺癌是全球女性最常见的恶性肿瘤之一,其中三阴性乳腺癌(TNBC)约占所有乳腺癌的15%到20%.TNBC 由于缺乏特异性的治疗靶点,且更易发生化疗药耐药,因此其临床预后较差.越来越多的证据表明lncRNAs 是TNBC 潜在的预后因素.
其他文献
目的 长链非编码RNA MALAT1(LncRNA MALAT1)在头颈部鳞癌中异常表达,探索LncRNA MALAT1影响头颈部鳞癌生长侵袭的具体作用和机制。方法 原位杂交和免疫组化分别检测并LncRNA MALAT1 和VHL 在头颈部鳞癌中的表达情况和表达相关性,GEO 数据库分析LncRNA MALAT1 和VHL 在头颈部鳞癌中的表达及相关性;利用小干扰RNA 敲低LncRNA MALA
Objective The phosphorylation of EphA2 at serine 897(pS897-EphA2)plays a key role in the ligand-independent functions of EphA2.The ligand-independent promotion of cancer cell migration and invasion by
Objective EphA2 and interleukin-6(IL6)have been implicated in cancer metastasis and stem properties,but the link between EphA2 and IL6 in cancer is unknown.
Objective Solid tumors are characterized by containing poorly vascularized regions(hypoxia)which are typically associated with poor clinical outcomes,like tumor recurrence,metastasis and chemotherapy
目的 鉴定与HNRNPAB表达显著相关的lncRNA 分子,初步探索HNRNPAB-lncRNA 在肝癌发生发展中的调控机制.方法 应用LncRNA 芯片检测肝癌细胞经过HNRNPAB 干扰或过表达质粒转染前后的lncRNA 表达谱,以P<0.05 的统计学差异为标准,筛选HNRNPAB 的潜在下游lncRNA,并在肝癌细胞系、肝癌组织RNA 中验证目标lncRNA 与HNRNPAB 的相关性,通
Objective To investigate the anticancer effect of doxorubicin loaded nanometer(DLN)with miR-21 inhibitor in melanoma,and to assess its mechanism.
Objective Identification of key molecules of metastasis that can be targeted for therapy may help improve outcomes for NPC patients.One such potential molecule is Annexin A1(ANXA1),which is a possible
Objective Accumulative data suggest that metadherin(MTDH)may function as an oncogene.Our previous study showed that MTDH promotes hepatocellular carcinoma(HCC)metastasis via the epithelial-mesenchymal
Objective Extrahepatic metastasis is commonly regarded as a symbol of advanced stage of HCC and accounts for about 10%of HCC patients.According to the Barcelona Clinic Liver Cancer(BCLC)staging system
目的 探索肝细胞癌(HCC)患者行肝切除术后1周的血清甲胎蛋白(AFP)变化情况的预后评估价值。方法 我们收集了符合入组标准的2009-2011 期间在复旦大学附属中山医院初诊为HCC 并行根治性切除术作为首次治疗的598 例患者作为探索队列,记录其术前AFP 水平(AFP0)及术后1 周时的AFP水平(AFP7)并根据如下公式计算AFP 应答情况(AR)∶AR = lgAFP7/lgAFP0(l